American Association for Cancer Research

AACR Cancer Policy Monitor

Bookmark and Share
September 2011



Moran, Platts, Wasserman-Schultz recognized with Distinguished Public Service Awards

The AACR celebrated three leaders in Congress last week for their commitment and dedication to the conquest of cancer. Sen. Jerry Moran (R-Kan.), Rep. Debbie Wasserman Schultz (D-Fla.) and Rep. Todd Platts (R-Penn.) were each honored with an AACR Distinguished Public Service Award during a reception on Capitol Hill, which took place during a full week of events in Washington, D.C., organized by the AACR to draw attention to the importance of investment in cancer research and encourage continued congressional support for the National Institutes of Health (NIH) and the National Cancer Institute (NCI).

All three lawmakers were chosen by the AACR Science Policy and Legislative Affairs Committee, a distinguished panel of scientists who serve as the AACR’s principal means for devising and implementing strategies to influence important biomedical research-related public policy issues.

Sen. Jerry Moran (R-Kan.) was elected to the Senate last fall, after representing the first district of Kansas for 14 years in the U.S. House of Representatives. Moran’s appointment this year to the Senate Appropriations Committee and specifically, the Subcommittee on Labor, Health and Human Services, Education, has allowed him to continue the strong support for biomedical research that he demonstrated while serving in the House of Representatives.

The AACR is deeply grateful for Moran’s strong engagement on and interest in the work taking place through the NIH and NCI, and appreciates his efforts to advocate for increased funding through his role as a Senate appropriator. On the same day that he recieved the award, Moran had offered an amendment during the Senate full committee mark-up of the fiscal year 2012 Labor-HHS-Education Appropriations bill to increase funding for the NIH. Although the amendment was not approved, Moran's efforts were deeply appreciated.

Moran Group

Pictured above: Roy Jensen, M.D., director of the University of Kansas Cancer Center, AACR CEO Margaret Foti, Ph.D., M.D. (h.c.), Senator Jerry Moran (R-Kan.) and AACR President Judy Garber, M.D., M.P.H.

Rep. Debbie Wasserman Schultz (D-Fla.) has been a true champion for early cancer detection and prevention. This was most notably demonstrated through her successful efforts to include a provision in the Patient Protection and Affordable Care Act that directs the Centers for Disease Control and Prevention to develop and implement a national education campaign about the threat breast cancer poses to all young women, with particular attention to high-risk ethnic, cultural and racial groups.

Wasserman Schultz has represented the 20th district of Florida since 2005 in the House of Representatives. She serves on the House Budget Committee, where she has proven to be a powerful advocate for NIH funding and cancer research.

WassermanShultz and Dalton

Pictured above: AACR CEO Margaret Foti, Ph.D., M.D. (h.c.), William Dalton, Ph.D., M.D., Rep. Debbie Wasserman Schultz (D-Fla.) and AACR President Judy Garber, M.D., M.P.H.

Rep. Todd Platts (R-Penn.) has demonstrated tremendous leadership on the issue of tobacco and public health, and has worked to ensure adequate funding for the NIH and NCI. The AACR especially applauds his sponsorship of the Family Smoking Prevention and Tobacco Control Act of 2009, which gave the U.S. Food and Drug Administration the authority to regulate tobacco products for the first time. Platts has represented the 19th district of Pennsylvania for more than a decade, and he holds leadership positions in the Congressional Task Force on Tobacco and Health and the Congressional Heart and Stroke Coalition. He has also been a leading Republican advocate for NIH and NCI funding.


Foti, Platts, Garber

Pictured above: AACR CEO Margaret Foti, Ph.D., M.D. (h.c.), Rep. Todd Platts (R-Penn.) and AACR President Judy Garber, M.D., M.P.H.

Read More from the September Edition of the AACR Cancer Policy Monitor: